Neuro65/AOCN2024

Presentation information

Print

Luncheon Seminar

Japanese

[LS-28] Luncheon Seminar 28「New Hope for the Treatment of Generalized Myasthenia Gravis: Expanding Options with Rozanolixizumab and Zilucoplan」

Fri. May 31, 2024 12:00 PM - 1:00 PM Room2 (Hall B7 (1), B Block, 7F, TIF)

Chair(s): Tomihiro Imai (Department of Neurology, Centre for Neuromuscular and Intractable Diseases, National Hakone Hospital, Japan), Satoshi Kuwabara (Department of Neurology, Graduate School of Medicine, Chiba University, Japan)

Sponsored by: UCB Japan Co. Ltd.

[LS-28-1] Key Points for Differential Diagnosis of MG and Expectations for Rozanolixizumab, a Novel FcRn Inhibitor

Kenji Sekiguchi (Division of Neurology, Kobe University Graduate School of Medicine, Japan)